Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sigrun Smola

Showing results (1-10 of 118) with videos related to

Pageof 12
Sort By:
Advances in Experimental Medicine and Biology|September 11, 2014
Human papillomaviruses and skin cancerSigrun Smola
Oncoimmunology|May 4, 2016
RIPK3-a predictive marker for personalized immunotherapy?Sigrun Smola
Viruses|September 13, 2017
Immunopathogenesis of HPV-Associated Cancers and Prospects for ImmunotherapySigrun Smola
Advances in Experimental Medicine and Biology|September 12, 2020
Human Papillomaviruses and Skin CancerSigrun Smola
Papillomavirus Research (Amsterdam, Netherlands)|April 14, 2019
Immune deviation and cervical carcinogenesisSigrun Smola
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 13, 2004
Novel immunosuppressive properties of interleukin-6 in dendritic cells: inhibition of NF-kappaB binding activity and CCR7 expressionSubramanya Hegde, Jenny Pahne, Sigrun Smola-Hess
Frontiers in Microbiology|December 1, 2018
Editorial: Human Papillomaviruses and Polyomaviruses in Skin CancerHerbert Johannes Pfister, Marisa Gariglio, Sigrun Smola
International Journal of Molecular Medicine|January 5, 2006
Integrin beta4, keratinocytes and papillomavirus infectionMonika Oldak, Sigrun Smola-Hess, Radoslaw Maksym
Therapeutic Advances in Vaccines|August 11, 2017
Human papillomavirus-driven immune deviation: challenge and novel opportunity for immunotherapySigrun Smola, Connie Trimble, Peter L Stern
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|April 9, 2019
Cross-talk of cutaneous beta human papillomaviruses and the immune system: determinants of disease penetranceAssunta Venuti, Stefan Lohse, Massimo Tommasino, et al.
Pageof 12

Showing results (1-10 of 118) with videos related to

Sort By:
Pageof 12
Advances in Experimental Medicine and Biology|September 11, 2014
Human papillomaviruses and skin cancerSigrun Smola
Oncoimmunology|May 4, 2016
RIPK3-a predictive marker for personalized immunotherapy?Sigrun Smola
Viruses|September 13, 2017
Immunopathogenesis of HPV-Associated Cancers and Prospects for ImmunotherapySigrun Smola
Advances in Experimental Medicine and Biology|September 12, 2020
Human Papillomaviruses and Skin CancerSigrun Smola
Papillomavirus Research (Amsterdam, Netherlands)|April 14, 2019
Immune deviation and cervical carcinogenesisSigrun Smola
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 13, 2004
Novel immunosuppressive properties of interleukin-6 in dendritic cells: inhibition of NF-kappaB binding activity and CCR7 expressionSubramanya Hegde, Jenny Pahne, Sigrun Smola-Hess
Frontiers in Microbiology|December 1, 2018
Editorial: Human Papillomaviruses and Polyomaviruses in Skin CancerHerbert Johannes Pfister, Marisa Gariglio, Sigrun Smola
International Journal of Molecular Medicine|January 5, 2006
Integrin beta4, keratinocytes and papillomavirus infectionMonika Oldak, Sigrun Smola-Hess, Radoslaw Maksym
Therapeutic Advances in Vaccines|August 11, 2017
Human papillomavirus-driven immune deviation: challenge and novel opportunity for immunotherapySigrun Smola, Connie Trimble, Peter L Stern
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|April 9, 2019
Cross-talk of cutaneous beta human papillomaviruses and the immune system: determinants of disease penetranceAssunta Venuti, Stefan Lohse, Massimo Tommasino, et al.
Pageof 12